Arkolith/Insider Trading/PCRX/Form 4

Cross Shawn

Chief Financial OfficerPacira BioSciences, Inc. (PCRX) · full profile →Form 4 · filed Apr 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$303K
Net Open-Market Flow
-$303K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 22, 2026Option exercise(M)2K$16.45$25K107K
Apr 22, 2026Sell(S)2K$25.01$38K105K
Apr 21, 2026Option exercise(M)3K$16.45$47K108K
Apr 21, 2026Sell(S)3K$25.01$71K105K
Apr 20, 2026Option exercise(M)8K$16.45$127K113K
Apr 20, 2026Sell(S)8K$25.14$194K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 22, 2026Option exercise(M)2K—$0163K
Apr 21, 2026Option exercise(M)3K—$0164K
Apr 20, 2026Option exercise(M)8K—$0167K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-026669) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML